SONX Stock Overview
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.
Sonendo, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.13|
|52 Week High||US$2.95|
|52 Week Low||US$0.091|
|1 Month Change||-50.75%|
|3 Month Change||-86.19%|
|1 Year Change||-94.91%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-98.54%|
Recent News & Updates
Analysts Have Just Cut Their Sonendo, Inc. (NYSE:SONX) Revenue Estimates By 18%Nov 10
A Piece Of The Puzzle Missing From Sonendo, Inc.'s (NYSE:SONX) Share PriceApr 19
Sonendo unit PIPStek files patent infringement lawsuit against BiolaseJan 04
GAAP EPS of -$0.47 misses by $0.08, revenue of $9.8M beats by $0.49MNov 09
Sonendo announces $63 million private placementSep 23
Sonendo: Painful Debut For This Dental PlayNov 07
|SONX||US Medical Equipment||US Market|
Return vs Industry: SONX underperformed the US Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: SONX underperformed the US Market which returned 11.7% over the past year.
|SONX Average Weekly Movement||29.3%|
|Medical Equipment Industry Average Movement||8.1%|
|Market Average Movement||6.1%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||2.9%|
Stable Share Price: SONX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week.
Volatility Over Time: SONX's weekly volatility has increased from 20% to 29% over the past year.
About the Company
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system.
Sonendo, Inc. Fundamentals Summary
|SONX fundamental statistics|
Is SONX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SONX income statement (TTM)|
|Cost of Revenue||US$32.84m|
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
|Earnings per share (EPS)||-1.12|
|Net Profit Margin||-137.14%|
How did SONX perform over the long term?See historical performance and comparison